Literature DB >> 17264972

Descriptive study of gallbladder, extrahepatic bile duct, and ampullary cancers in the United States, 1997-2002.

M T Goodman1, Jennifer Yamamoto.   

Abstract

OBJECTIVE: Few investigations of biliary tract (gallbladder, extrahepatic bile duct, ampulla of Vater) cancers have been conducted because of the relative rarity of these malignancies. The objective of this analysis was to compare the demographic, pathological, and clinical features of biliary tract cancers among men and women.
METHODS: Biliary tract cancers among 11,261 men and 15,722 women were identified through 33 US population-based registries during the period 1997-2002. These registries were estimated to represent 61% of the US population. Age-adjusted incidence rates (AAIR) were calculated per 100,000 population using counts derived from the 2000 US census.
RESULTS: The AAIR for gallbladder cancer among men (0.82 per 100,000) was significantly lower than the AAIR among women (1.45 per 100,000). By contrast, rates for extrahepatic bile duct and ampullary cancers were significantly higher among men (0.93 per 100,000 and 0.70 per 100,000, respectively) than among women (0.61 per 100,000 and 0.45 per 100,000, respectively). White men and women had significantly lower AAIRs for gallbladder cancer compared with other racial-ethnic groups, with the highest rates among Hispanics, American Indian-Alaska Natives, and Asian-Pacific Islanders. Asian-Pacific Islanders and Hispanics of both sexes had the highest AAIRs for extrahepatic bile duct and ampullary cancers. Ampullary tumors were more likely to be diagnosed at a localized or regional stage than were cancers of the gallbladder and extrahepatic bile duct. Asian-Pacific Islander men and women tended to have more unstaged cancers than other groups.
CONCLUSIONS: This population-based study suggests distinct etiologies of anatomic subsites of biliary tract cancer and caution against analytic investigations of all biliary tract cancers combined.

Entities:  

Mesh:

Year:  2007        PMID: 17264972     DOI: 10.1007/s10552-006-0109-4

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  17 in total

1.  Metastatic Signet Ring Cell Carcinoma of the Ampulla of Vater with an Unusually Prolonged Survival.

Authors:  Chandana Javvaji; Jacob R Bledsoe; Lloyd Hutchinson; Ediz F Cosar; Lacey J McIntosh; Venu G Bathini
Journal:  J Gastrointest Cancer       Date:  2020-03

2.  Role of Adjuvant Multimodality Therapy After Curative-Intent Resection of Ampullary Carcinoma.

Authors:  Brett L Ecker; Charles M Vollmer; Stephen W Behrman; Valentina Allegrini; John Aversa; Chad G Ball; Courtney E Barrows; Adam C Berger; Martha N Cagigas; John D Christein; Elijah Dixon; William E Fisher; Mollie Freedman-Weiss; Francisco Guzman-Pruneda; Robert H Hollis; Michael G House; Tara S Kent; Stacy J Kowalsky; Giuseppe Malleo; Ronald R Salem; Roberto Salvia; Carl R Schmidt; Thomas F Seykora; Richard Zheng; Amer H Zureikat; Paxton V Dickson
Journal:  JAMA Surg       Date:  2019-08-01       Impact factor: 14.766

3.  Trends in incidence and management of cancer of the ampulla of Vater.

Authors:  Florian Rostain; Samia Hamza; Antoine Drouillard; Jean Faivre; Anne-Marie Bouvier; Côme Lepage
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

4.  The occurrence of rare cancers in U.S. adults, 1995-2004.

Authors:  Robert T Greenlee; Marc T Goodman; Charles F Lynch; Charles E Platz; Lori A Havener; Holly L Howe
Journal:  Public Health Rep       Date:  2010 Jan-Feb       Impact factor: 2.792

5.  Biliary tract cancer incidence and trends in the United States by demographic group, 1999-2013.

Authors:  Alison L Van Dyke; Meredith S Shiels; Gieira S Jones; Ruth M Pfeiffer; Jessica L Petrick; Jennifer L Beebe-Dimmer; Jill Koshiol
Journal:  Cancer       Date:  2019-01-15       Impact factor: 6.860

6.  Determining the Adequate Examined Lymph Node Count in Resected Ampullary Adenocarcinoma-A National Cohort Study.

Authors:  Ibrahim Nassour; Alana Christie; Michael A Choti; John C Mansour; Rebecca M Minter; Patricio M Polanco; Mathew M Augustine; Matthew R Porembka; Xian-Jin Xie; Sam C Wang
Journal:  J Gastrointest Surg       Date:  2018-03-15       Impact factor: 3.452

7.  Effect of histone deacetylase inhibitor on proliferation of biliary tract cancer cell lines.

Authors:  Li-Ning Xu; Xin Wang; Sheng-Quan Zou
Journal:  World J Gastroenterol       Date:  2008-04-28       Impact factor: 5.742

8.  Biliary tract cancer incidence in the United States-Demographic and temporal variations by anatomic site.

Authors:  Felipe A Castro; Jill Koshiol; Ann W Hsing; Susan S Devesa
Journal:  Int J Cancer       Date:  2013-04-11       Impact factor: 7.396

9.  Family History of Cancer and Risk of Biliary Tract Cancers: Results from the Biliary Tract Cancers Pooling Project.

Authors:  Alison L Van Dyke; Margaret S Langhamer; Bin Zhu; Ruth M Pfeiffer; Demetrius Albanes; Gabriella Andreotti; Laura E Beane Freeman; Andrew T Chan; Neal D Freedman; Susan M Gapstur; Graham G Giles; Francine Grodstein; Linda M Liao; Juhua Luo; Roger L Milne; Kristine R Monroe; Marian L Neuhouser; Jenny N Poynter; Mark P Purdue; Kim Robien; Catherine Schairer; Rashmi Sinha; Stephanie Weinstein; Xuehong Zhang; Jessica L Petrick; Katherine A McGlynn; Peter T Campbell; Jill Koshiol
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2018-01-16       Impact factor: 4.254

10.  Racial and ethnic disparities in a national cohort of ampullary cancer patients.

Authors:  Ibrahim Nassour; Ali A Mokdad; Rebecca M Minter; Patricio M Polanco; Mathew M Augustine; John C Mansour; Matthew R Porembka; Sam C Wang
Journal:  J Surg Oncol       Date:  2017-10-02       Impact factor: 3.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.